Header Logo

Connection

Naoko Takebe to Proto-Oncogene Proteins c-met

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Proto-Oncogene Proteins c-met.
Naoko Takebe
Connection Strength
0.246
Proto-Oncogene Proteins c-met
  1. Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2. Clin Cancer Res. 2026 Apr 01; 32(7):1224-1233.
    View in: PubMed
    Score: 0.246
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.